Women’s Wear Daily
04.16.2014
fashion-scoops
fashion-scoops

Giorgio Armani, Luxottica Ink Eyewear Deal

The 10-year agreement will begin on Jan. 1, and the first collection will be presented during the year.

fashion-scoops/news
Most Recent Articles In Fashion Scoops
Most Recent Articles In Fashion Scoops More Articles By

MILAN — Giorgio Armani SpA and Luxottica Group announced Friday they had inked a licensing agreement for the production and worldwide distribution of eyewear collections under the Giorgio Armani, Emporio Armani and A|X Armani Exchange brands. This follows news in November that the two groups had reached a preliminary agreement on the license.

The 10-year agreement will begin on Jan. 1, and the first collection will be presented during the year.

Luxottica said in a statement that the license is expected to generate annual sales exceeding 200 million euros, or $250.3 million at current exchange, “after the initial launch period and once distribution has been fully rolled out across key geographies and channels.”

This marks a return to Luxottica for the designer, who first licensed his eyewear to the Italian firm in 1988. Luxottica then lost the license to Safilo SpA, whose first Armani collections came out in 2003.

Luxottica owns the Oakley and Ray-Ban labels and holds eyewear licenses with brands such as Bulgari, Burberry, Chanel, Dolce & Gabbana, Donna Karan, Polo Ralph Lauren, Prada, Tiffany and Versace.

load comments

ADD A COMMENT

Sign in using your Facebook or Twitter account, or simply type your comment below as a guest by entering your email and name. Your email address will not be shared. Please note that WWD reserves the right to remove profane, distasteful or otherwise inappropriate language.

Ads by Google

Newsletters
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

Publications

ArticleFinder

Fashion


Choose By

Clear

How it works

Close

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.


Or